ArticleClinical and experimental gastroenterology2020

Toll-Like Receptor 3 as a Recurrence Risk Factor and a Potential Molecular Therapeutic Target in Colorectal Cancer.

Tatsuya Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.